Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 15;21(1):7.
doi: 10.1186/s13053-023-00251-7.

Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres

Affiliations

Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres

Anna Byrjalsen et al. Hered Cancer Clin Pract. .

Abstract

The end of each chromosome consists of a DNA region termed the telomeres. The telomeres serve as a protective shield against degradation of the coding DNA sequence, as the DNA strand inevitably ‒ with each cell division ‒ is shortened. Inherited genetic variants cause telomere biology disorders when located in genes (e.g. DKC1, RTEL1, TERC, TERT) playing a role in the function and maintenance of the telomeres. Subsequently patients with telomere biology disorders associated with both too short or too long telomeres have been recognized. Patients with telomere biology disorders associated with short telomeres are at increased risk of dyskeratosis congenita (nail dystrophy, oral leukoplakia, and hyper- or hypo-pigmentation of the skin), pulmonary fibrosis, hematologic disease (ranging from cytopenia to leukemia) and in rare cases very severe multiorgan manifestations and early death. Patients with telomere biology disorders associated with too long telomeres have in recent years been found to confer an increased risk of melanoma and chronic lymphocytic leukemia. Despite this, many patients have an apparently isolated manifestation rendering telomere biology disorders most likely underdiagnosed. The complexity of telomere biology disorders and many causative genes makes it difficult to design a surveillance program which will ensure identification of early onset disease manifestation without overtreatment.

Keywords: Cancer predisposition; Long telomeres; Lung fibrosis; Short telomeres; Telomere biology disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The components of the telomere. The outermost part of the telomeres is protected by a Shelterin complex consisting of six proteins: TRF1, TRF2, TIN2, POT1, TPP1 and RAP1. The telomeres are maintained at each cell division by a telomerase consisting of telomerase reverse transcriptase (TERT) and an RNA part that acts as a template when the nucleotides must be inserted during replication of the telomeres (TERC and DKC1). In addition, a number of proteins contribute to the maintenance and function of the telomeres. This applies to the CST complex (CTC1, STN1 and TEN1) and RTEL1, TCAB1 and PARN. The inheritance pattern is implicated by coloring. Pink: autosomal recessive inheritance; Yellow: autosomal dominant inheritance; Blue: autosomal recessive and autosomal dominant inheritance; Red: X-linked recessive inheritance. Proteins shown but not yet reported associated with TBD are colored in gray
Fig. 2
Fig. 2
The most common clinical manifestations of telomere biology disorders (TBD). Arrows and icons show organ system affected by TBD
Fig. 3
Fig. 3
High Resolution Computerised Tomography (HRCT) showing lung fibrosis in a patient with a pathogenic variant in TERC. A and B Severe fibrotic and cystic changes in a patient with TBD and dyskeratosis congenita due to a pathogenic variant in TERC prior to lung transplantation. C HRCT in a patient with no lung disease and TBD

References

    1. Niewisch MR, Savage SA. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2019;12(12):1037–52. doi: 10.1080/17474086.2019.1662720. - DOI - PMC - PubMed
    1. Savage SA. Beginning at the ends: telomeres and human disease. F1000Res. 2018;7:F1000. Faculty Rev-524. 10.12688/f1000research.14068.1. - PubMed
    1. Diez Roux AV, Ranjit N, Jenny NS, Shea S, Cushman M, Fitzpatrick A, et al. Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis. Aging Cell. 2009;8(3):251–257. doi: 10.1111/j.1474-9726.2009.00470.x. - DOI - PMC - PubMed
    1. Lin J, Cheon J, Brown R, Coccia M, Puterman E, Aschbacher K, et al. Systematic and Cell Type-Specific Telomere Length Changes in Subsets of Lymphocytes. J Immunol Res. 2016;2016:5371050. 10.1155/2016/5371050. - PMC - PubMed
    1. Alder JK, Hanumanthu VS, Strong MA, DeZern AE, Stanley SE, Takemoto CM, et al. Diagnostic utility of telomere length testing in a hospital-based setting. Proc Natl Acad Sci U S A. 2018;115(10):E2358–E2365. doi: 10.1073/pnas.1720427115. - DOI - PMC - PubMed

LinkOut - more resources